nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—Fluspirilene—Ezetimibe—coronary artery disease	0.252	1	CrCrCtD
Haloperidol—CYP2C19—coronary artery disease	0.0803	0.552	CbGaD
Haloperidol—HTR2A—coronary artery disease	0.0651	0.448	CbGaD
Haloperidol—HTR1B—Penbutolol—coronary artery disease	0.0251	0.0689	CbGbCtD
Haloperidol—CYP3A7—Eplerenone—coronary artery disease	0.0101	0.0277	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0101	0.0277	CbGbCtD
Haloperidol—ABCB1—Ticagrelor—coronary artery disease	0.0086	0.0236	CbGbCtD
Haloperidol—CYP3A5—Clopidogrel—coronary artery disease	0.00817	0.0224	CbGbCtD
Haloperidol—CYP2C9—Fenofibrate—coronary artery disease	0.0079	0.0217	CbGbCtD
Haloperidol—CYP2C19—Gemfibrozil—coronary artery disease	0.0076	0.0208	CbGbCtD
Haloperidol—CYP3A5—Eplerenone—coronary artery disease	0.00759	0.0208	CbGbCtD
Haloperidol—KCNH2—purkinje fiber—coronary artery disease	0.00715	0.188	CbGeAlD
Haloperidol—CYP1A2—Gemfibrozil—coronary artery disease	0.00701	0.0192	CbGbCtD
Haloperidol—CYP2C19—Clopidogrel—coronary artery disease	0.00659	0.0181	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00652	0.0179	CbGbCtD
Haloperidol—CYP3A7—Simvastatin—coronary artery disease	0.00652	0.0179	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00638	0.0175	CbGbCtD
Haloperidol—CYP3A7—Lovastatin—coronary artery disease	0.00638	0.0175	CbGbCtD
Haloperidol—CYP2C9—Gemfibrozil—coronary artery disease	0.00632	0.0173	CbGbCtD
Haloperidol—CYP1A2—Clopidogrel—coronary artery disease	0.00608	0.0167	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00581	0.0159	CbGbCtD
Haloperidol—CYP3A7—Atorvastatin—coronary artery disease	0.00581	0.0159	CbGbCtD
Haloperidol—CYP2C19—Telmisartan—coronary artery disease	0.00576	0.0158	CbGbCtD
Haloperidol—CYP2C9—Clopidogrel—coronary artery disease	0.00548	0.015	CbGbCtD
Haloperidol—ABCB1—Perindopril—coronary artery disease	0.00531	0.0146	CbGbCtD
Haloperidol—ABCB1—Clopidogrel—coronary artery disease	0.00531	0.0146	CbGbCtD
Haloperidol—CYP3A5—Rosuvastatin—coronary artery disease	0.00526	0.0144	CbGbCtD
Haloperidol—CYP3A4—Ticagrelor—coronary artery disease	0.00515	0.0141	CbGbCtD
Haloperidol—CYP3A5—Simvastatin—coronary artery disease	0.00489	0.0134	CbGbCtD
Haloperidol—CYP3A5—Lovastatin—coronary artery disease	0.00479	0.0131	CbGbCtD
Haloperidol—CYP3A5—Pravastatin—coronary artery disease	0.00479	0.0131	CbGbCtD
Haloperidol—CYP2C9—Pitavastatin—coronary artery disease	0.00479	0.0131	CbGbCtD
Haloperidol—CYP2C9—Valsartan—coronary artery disease	0.00466	0.0128	CbGbCtD
Haloperidol—ABCB1—Pitavastatin—coronary artery disease	0.00465	0.0127	CbGbCtD
Haloperidol—ABCB1—Telmisartan—coronary artery disease	0.00465	0.0127	CbGbCtD
Haloperidol—CYP2C19—Timolol—coronary artery disease	0.00464	0.0127	CbGbCtD
Haloperidol—HTR2B—cardial valve—coronary artery disease	0.00462	0.121	CbGeAlD
Haloperidol—CYP3A4—Fenofibrate—coronary artery disease	0.00459	0.0126	CbGbCtD
Haloperidol—ABCB1—Enalapril—coronary artery disease	0.0044	0.0121	CbGbCtD
Haloperidol—ABCB1—Lisinopril—coronary artery disease	0.0044	0.0121	CbGbCtD
Haloperidol—CYP3A5—Atorvastatin—coronary artery disease	0.00436	0.012	CbGbCtD
Haloperidol—CYP2C19—Rosuvastatin—coronary artery disease	0.00424	0.0116	CbGbCtD
Haloperidol—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00414	0.0113	CbGbCtD
Haloperidol—CYP3A5—Losartan—coronary artery disease	0.00399	0.0109	CbGbCtD
Haloperidol—CYP2C19—Simvastatin—coronary artery disease	0.00395	0.0108	CbGbCtD
Haloperidol—CYP2C19—Lovastatin—coronary artery disease	0.00386	0.0106	CbGbCtD
Haloperidol—CYP2D6—Niacin—coronary artery disease	0.0038	0.0104	CbGbCtD
Haloperidol—ABCB1—Timolol—coronary artery disease	0.00374	0.0103	CbGbCtD
Haloperidol—KCNH2—endocardium—coronary artery disease	0.00368	0.0967	CbGeAlD
Haloperidol—CYP3A4—Gemfibrozil—coronary artery disease	0.00367	0.0101	CbGbCtD
Haloperidol—CYP2C9—Rosuvastatin—coronary artery disease	0.00353	0.00968	CbGbCtD
Haloperidol—CYP2D6—Timolol—coronary artery disease	0.00353	0.00967	CbGbCtD
Haloperidol—CYP2C19—Atorvastatin—coronary artery disease	0.00352	0.00964	CbGbCtD
Haloperidol—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00344	0.00943	CbGbCtD
Haloperidol—ABCB1—Ezetimibe—coronary artery disease	0.00342	0.00939	CbGbCtD
Haloperidol—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00334	0.00915	CbGbCtD
Haloperidol—ABCB1—Captopril—coronary artery disease	0.0033	0.00904	CbGbCtD
Haloperidol—CYP2C9—Simvastatin—coronary artery disease	0.00328	0.00899	CbGbCtD
Haloperidol—CYP2C19—Losartan—coronary artery disease	0.00322	0.00882	CbGbCtD
Haloperidol—CYP2C9—Lovastatin—coronary artery disease	0.00321	0.0088	CbGbCtD
Haloperidol—CYP2C9—Pravastatin—coronary artery disease	0.00321	0.0088	CbGbCtD
Haloperidol—CYP3A4—Clopidogrel—coronary artery disease	0.00318	0.00873	CbGbCtD
Haloperidol—ABCB1—Simvastatin—coronary artery disease	0.00318	0.00873	CbGbCtD
Haloperidol—ABCB1—Pravastatin—coronary artery disease	0.00312	0.00854	CbGbCtD
Haloperidol—ABCB1—Lovastatin—coronary artery disease	0.00312	0.00854	CbGbCtD
Haloperidol—CYP2D6—Captopril—coronary artery disease	0.00311	0.00852	CbGbCtD
Haloperidol—CYP2D6—Simvastatin—coronary artery disease	0.003	0.00822	CbGbCtD
Haloperidol—CYP2C9—cardial valve—coronary artery disease	0.00299	0.0786	CbGeAlD
Haloperidol—CYP1A2—Losartan—coronary artery disease	0.00297	0.00814	CbGbCtD
Haloperidol—CYP3A4—Eplerenone—coronary artery disease	0.00296	0.00812	CbGbCtD
Haloperidol—CYP2D6—Pravastatin—coronary artery disease	0.00294	0.00805	CbGbCtD
Haloperidol—CYP2D6—Lovastatin—coronary artery disease	0.00294	0.00805	CbGbCtD
Haloperidol—CYP2C9—Atorvastatin—coronary artery disease	0.00292	0.00802	CbGbCtD
Haloperidol—ABCB1—Atorvastatin—coronary artery disease	0.00284	0.00778	CbGbCtD
Haloperidol—CYP2C9—Losartan—coronary artery disease	0.00267	0.00733	CbGbCtD
Haloperidol—CYP2D6—Atorvastatin—coronary artery disease	0.00267	0.00733	CbGbCtD
Haloperidol—CYP3A4—Enalapril—coronary artery disease	0.00264	0.00723	CbGbCtD
Haloperidol—ABCB1—Losartan—coronary artery disease	0.0026	0.00712	CbGbCtD
Haloperidol—CYP3A4—Ezetimibe—coronary artery disease	0.00205	0.00563	CbGbCtD
Haloperidol—CYP3A4—Rosuvastatin—coronary artery disease	0.00205	0.00563	CbGbCtD
Haloperidol—CYP3A4—Simvastatin—coronary artery disease	0.00191	0.00523	CbGbCtD
Haloperidol—CYP3A4—Pravastatin—coronary artery disease	0.00187	0.00512	CbGbCtD
Haloperidol—CYP3A4—Lovastatin—coronary artery disease	0.00187	0.00512	CbGbCtD
Haloperidol—CYP3A4—Atorvastatin—coronary artery disease	0.0017	0.00466	CbGbCtD
Haloperidol—CYP3A4—Losartan—coronary artery disease	0.00156	0.00426	CbGbCtD
Haloperidol—HTR2A—arteriole—coronary artery disease	0.00152	0.04	CbGeAlD
Haloperidol—HTR2A—pulmonary artery—coronary artery disease	0.000998	0.0262	CbGeAlD
Haloperidol—HTR2A—sympathetic nervous system—coronary artery disease	0.000971	0.0255	CbGeAlD
Haloperidol—HTR2A—vagus nerve—coronary artery disease	0.00094	0.0247	CbGeAlD
Haloperidol—HTR2A—vein—coronary artery disease	0.000908	0.0238	CbGeAlD
Haloperidol—HTR1B—artery—coronary artery disease	0.000769	0.0202	CbGeAlD
Haloperidol—HTR1D—artery—coronary artery disease	0.000745	0.0195	CbGeAlD
Haloperidol—DRD4—heart—coronary artery disease	0.000695	0.0182	CbGeAlD
Haloperidol—HTR2A—autonomic nervous system—coronary artery disease	0.000652	0.0171	CbGeAlD
Haloperidol—CBR1—myocardium—coronary artery disease	0.000619	0.0163	CbGeAlD
Haloperidol—H1F0—cardiac ventricle—coronary artery disease	0.000539	0.0142	CbGeAlD
Haloperidol—H1F0—myocardium—coronary artery disease	0.000507	0.0133	CbGeAlD
Haloperidol—CBR1—heart—coronary artery disease	0.000432	0.0113	CbGeAlD
Haloperidol—CBR1—cardiovascular system—coronary artery disease	0.000408	0.0107	CbGeAlD
Haloperidol—SIGMAR1—cardiac ventricle—coronary artery disease	0.000389	0.0102	CbGeAlD
Haloperidol—Loperamide—POMC—coronary artery disease	0.000388	0.26	CrCbGaD
Haloperidol—HTR2A—artery—coronary artery disease	0.00037	0.00971	CbGeAlD
Haloperidol—CBR1—cardiac atrium—coronary artery disease	0.00037	0.0097	CbGeAlD
Haloperidol—SIGMAR1—myocardium—coronary artery disease	0.000366	0.00962	CbGeAlD
Haloperidol—H1F0—heart—coronary artery disease	0.000354	0.00929	CbGeAlD
Haloperidol—H1F0—cardiovascular system—coronary artery disease	0.000334	0.00877	CbGeAlD
Haloperidol—CBR1—blood—coronary artery disease	0.000322	0.00846	CbGeAlD
Haloperidol—HTR2A—endothelium—coronary artery disease	0.000313	0.0082	CbGeAlD
Haloperidol—KCNH2—cardiac ventricle—coronary artery disease	0.00031	0.00814	CbGeAlD
Haloperidol—H1F0—cardiac atrium—coronary artery disease	0.000303	0.00795	CbGeAlD
Haloperidol—KCNH2—myocardium—coronary artery disease	0.000292	0.00765	CbGeAlD
Haloperidol—HTR1B—cardiovascular system—coronary artery disease	0.000267	0.00702	CbGeAlD
Haloperidol—H1F0—blood—coronary artery disease	0.000264	0.00694	CbGeAlD
Haloperidol—CYP1A1—cardiac ventricle—coronary artery disease	0.000262	0.00687	CbGeAlD
Haloperidol—HTR1D—cardiovascular system—coronary artery disease	0.000259	0.00679	CbGeAlD
Haloperidol—SIGMAR1—heart—coronary artery disease	0.000256	0.00671	CbGeAlD
Haloperidol—HTR2B—heart—coronary artery disease	0.000255	0.0067	CbGeAlD
Haloperidol—HTR2B—cardiovascular system—coronary artery disease	0.000241	0.00632	CbGeAlD
Haloperidol—Moclobemide—CYP2C19—coronary artery disease	0.000227	0.152	CrCbGaD
Haloperidol—SIGMAR1—cardiac atrium—coronary artery disease	0.000219	0.00574	CbGeAlD
Haloperidol—Loperamide—OPRD1—coronary artery disease	0.000219	0.146	CrCbGaD
Haloperidol—Droperidol—HTR2A—coronary artery disease	0.000216	0.144	CrCbGaD
Haloperidol—KCNH2—heart—coronary artery disease	0.000204	0.00534	CbGeAlD
Haloperidol—Fluspirilene—ADRB1—coronary artery disease	0.000193	0.129	CrCbGaD
Haloperidol—KCNH2—cardiovascular system—coronary artery disease	0.000192	0.00504	CbGeAlD
Haloperidol—SIGMAR1—blood—coronary artery disease	0.000191	0.00501	CbGeAlD
Haloperidol—HTR2B—blood—coronary artery disease	0.00019	0.005	CbGeAlD
Haloperidol—KCNH2—cardiac atrium—coronary artery disease	0.000174	0.00457	CbGeAlD
Haloperidol—CYP1A1—heart—coronary artery disease	0.000172	0.00451	CbGeAlD
Haloperidol—CYP2C9—heart—coronary artery disease	0.000165	0.00434	CbGeAlD
Haloperidol—CYP2C19—blood—coronary artery disease	0.000159	0.00418	CbGeAlD
Haloperidol—CYP2C9—cardiovascular system—coronary artery disease	0.000156	0.0041	CbGeAlD
Haloperidol—KCNH2—blood—coronary artery disease	0.000152	0.00399	CbGeAlD
Haloperidol—CYP1A1—cardiac atrium—coronary artery disease	0.000147	0.00386	CbGeAlD
Haloperidol—Sertindole—HTR2A—coronary artery disease	0.000139	0.0931	CrCbGaD
Haloperidol—HTR2A—heart—coronary artery disease	0.000136	0.00358	CbGeAlD
Haloperidol—CYP1A2—blood—coronary artery disease	0.00013	0.00341	CbGeAlD
Haloperidol—HTR2A—cardiovascular system—coronary artery disease	0.000129	0.00337	CbGeAlD
Haloperidol—CYP1A1—blood—coronary artery disease	0.000128	0.00337	CbGeAlD
Haloperidol—CYP3A5—blood—coronary artery disease	0.000125	0.00329	CbGeAlD
Haloperidol—CYP2C9—blood—coronary artery disease	0.000123	0.00324	CbGeAlD
Haloperidol—Fluspirilene—HTR2A—coronary artery disease	0.000113	0.0759	CrCbGaD
Haloperidol—HTR2A—blood—coronary artery disease	0.000102	0.00267	CbGeAlD
Haloperidol—CYP3A4—blood—coronary artery disease	9.41e-05	0.00247	CbGeAlD
Haloperidol—CYP2D6—blood—coronary artery disease	9.26e-05	0.00243	CbGeAlD
Haloperidol—ABCB1—heart—coronary artery disease	8.93e-05	0.00234	CbGeAlD
Haloperidol—ABCB1—cardiovascular system—coronary artery disease	8.43e-05	0.00221	CbGeAlD
Haloperidol—ABCB1—blood—coronary artery disease	6.66e-05	0.00175	CbGeAlD
Haloperidol—Body temperature increased—Trandolapril—coronary artery disease	4.91e-05	0.00043	CcSEcCtD
Haloperidol—Dizziness—Ezetimibe—coronary artery disease	4.91e-05	0.00043	CcSEcCtD
Haloperidol—Body temperature increased—Enalapril—coronary artery disease	4.89e-05	0.000428	CcSEcCtD
Haloperidol—Feeling abnormal—Captopril—coronary artery disease	4.89e-05	0.000428	CcSEcCtD
Haloperidol—Insomnia—Losartan—coronary artery disease	4.89e-05	0.000428	CcSEcCtD
Haloperidol—Rash—Fenofibrate—coronary artery disease	4.89e-05	0.000428	CcSEcCtD
Haloperidol—Dermatitis—Fenofibrate—coronary artery disease	4.88e-05	0.000427	CcSEcCtD
Haloperidol—Decreased appetite—Furosemide—coronary artery disease	4.87e-05	0.000427	CcSEcCtD
Haloperidol—Headache—Fenofibrate—coronary artery disease	4.85e-05	0.000425	CcSEcCtD
Haloperidol—Vision blurred—Lisinopril—coronary artery disease	4.85e-05	0.000425	CcSEcCtD
Haloperidol—Urticaria—Telmisartan—coronary artery disease	4.85e-05	0.000425	CcSEcCtD
Haloperidol—Vomiting—Clopidogrel—coronary artery disease	4.84e-05	0.000424	CcSEcCtD
Haloperidol—Diarrhoea—Simvastatin—coronary artery disease	4.84e-05	0.000424	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Furosemide—coronary artery disease	4.84e-05	0.000424	CcSEcCtD
Haloperidol—Tremor—Lisinopril—coronary artery disease	4.83e-05	0.000423	CcSEcCtD
Haloperidol—Body temperature increased—Telmisartan—coronary artery disease	4.83e-05	0.000423	CcSEcCtD
Haloperidol—Dyspnoea—Losartan—coronary artery disease	4.82e-05	0.000422	CcSEcCtD
Haloperidol—Anxiety—Ramipril—coronary artery disease	4.82e-05	0.000422	CcSEcCtD
Haloperidol—Vomiting—Lovastatin—coronary artery disease	4.81e-05	0.000421	CcSEcCtD
Haloperidol—Somnolence—Losartan—coronary artery disease	4.81e-05	0.000421	CcSEcCtD
Haloperidol—Dizziness—Eplerenone—coronary artery disease	4.8e-05	0.000421	CcSEcCtD
Haloperidol—Rash—Clopidogrel—coronary artery disease	4.8e-05	0.000421	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	4.8e-05	0.000421	CcSEcCtD
Haloperidol—Dermatitis—Clopidogrel—coronary artery disease	4.8e-05	0.00042	CcSEcCtD
Haloperidol—Hypertension—Timolol—coronary artery disease	4.79e-05	0.00042	CcSEcCtD
Haloperidol—Constipation—Furosemide—coronary artery disease	4.79e-05	0.00042	CcSEcCtD
Haloperidol—Hypersensitivity—Niacin—coronary artery disease	4.79e-05	0.000419	CcSEcCtD
Haloperidol—Headache—Clopidogrel—coronary artery disease	4.77e-05	0.000418	CcSEcCtD
Haloperidol—Rash—Lovastatin—coronary artery disease	4.77e-05	0.000418	CcSEcCtD
Haloperidol—Dermatitis—Lovastatin—coronary artery disease	4.77e-05	0.000417	CcSEcCtD
Haloperidol—Anaemia—Lisinopril—coronary artery disease	4.76e-05	0.000417	CcSEcCtD
Haloperidol—Dyspepsia—Losartan—coronary artery disease	4.76e-05	0.000417	CcSEcCtD
Haloperidol—Feeling abnormal—Perindopril—coronary artery disease	4.75e-05	0.000416	CcSEcCtD
Haloperidol—Headache—Lovastatin—coronary artery disease	4.74e-05	0.000415	CcSEcCtD
Haloperidol—Pruritus—Valsartan—coronary artery disease	4.73e-05	0.000414	CcSEcCtD
Haloperidol—Dry mouth—Ramipril—coronary artery disease	4.73e-05	0.000414	CcSEcCtD
Haloperidol—Vomiting—Ezetimibe—coronary artery disease	4.72e-05	0.000413	CcSEcCtD
Haloperidol—Hypersensitivity—Pravastatin—coronary artery disease	4.71e-05	0.000413	CcSEcCtD
Haloperidol—Anxiety—Timolol—coronary artery disease	4.71e-05	0.000413	CcSEcCtD
Haloperidol—Pruritus—Olmesartan—coronary artery disease	4.71e-05	0.000412	CcSEcCtD
Haloperidol—Decreased appetite—Losartan—coronary artery disease	4.7e-05	0.000412	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	4.69e-05	0.000411	CcSEcCtD
Haloperidol—Body temperature increased—Captopril—coronary artery disease	4.69e-05	0.000411	CcSEcCtD
Haloperidol—Dizziness—Simvastatin—coronary artery disease	4.68e-05	0.00041	CcSEcCtD
Haloperidol—Rash—Ezetimibe—coronary artery disease	4.68e-05	0.00041	CcSEcCtD
Haloperidol—Dermatitis—Ezetimibe—coronary artery disease	4.67e-05	0.000409	CcSEcCtD
Haloperidol—Confusional state—Ramipril—coronary artery disease	4.67e-05	0.000409	CcSEcCtD
Haloperidol—Headache—Ezetimibe—coronary artery disease	4.65e-05	0.000407	CcSEcCtD
Haloperidol—Oedema—Ramipril—coronary artery disease	4.63e-05	0.000406	CcSEcCtD
Haloperidol—Anaphylactic shock—Ramipril—coronary artery disease	4.63e-05	0.000406	CcSEcCtD
Haloperidol—Vertigo—Lisinopril—coronary artery disease	4.63e-05	0.000405	CcSEcCtD
Haloperidol—Dry mouth—Timolol—coronary artery disease	4.62e-05	0.000405	CcSEcCtD
Haloperidol—Constipation—Losartan—coronary artery disease	4.62e-05	0.000405	CcSEcCtD
Haloperidol—Vomiting—Eplerenone—coronary artery disease	4.62e-05	0.000404	CcSEcCtD
Haloperidol—Feeling abnormal—Furosemide—coronary artery disease	4.62e-05	0.000404	CcSEcCtD
Haloperidol—Leukopenia—Lisinopril—coronary artery disease	4.61e-05	0.000404	CcSEcCtD
Haloperidol—Nausea—Fenofibrate—coronary artery disease	4.6e-05	0.000403	CcSEcCtD
Haloperidol—Pruritus—Niacin—coronary artery disease	4.6e-05	0.000403	CcSEcCtD
Haloperidol—Rash—Eplerenone—coronary artery disease	4.58e-05	0.000401	CcSEcCtD
Haloperidol—Urticaria—Perindopril—coronary artery disease	4.58e-05	0.000401	CcSEcCtD
Haloperidol—Hypersensitivity—Trandolapril—coronary artery disease	4.58e-05	0.000401	CcSEcCtD
Haloperidol—Dermatitis—Eplerenone—coronary artery disease	4.58e-05	0.000401	CcSEcCtD
Haloperidol—Diarrhoea—Valsartan—coronary artery disease	4.57e-05	0.0004	CcSEcCtD
Haloperidol—Confusional state—Timolol—coronary artery disease	4.57e-05	0.0004	CcSEcCtD
Haloperidol—Hypersensitivity—Enalapril—coronary artery disease	4.56e-05	0.000399	CcSEcCtD
Haloperidol—Body temperature increased—Perindopril—coronary artery disease	4.56e-05	0.000399	CcSEcCtD
Haloperidol—Diarrhoea—Olmesartan—coronary artery disease	4.55e-05	0.000399	CcSEcCtD
Haloperidol—Headache—Eplerenone—coronary artery disease	4.55e-05	0.000399	CcSEcCtD
Haloperidol—Nervous system disorder—Ramipril—coronary artery disease	4.55e-05	0.000398	CcSEcCtD
Haloperidol—Thrombocytopenia—Ramipril—coronary artery disease	4.54e-05	0.000397	CcSEcCtD
Haloperidol—Oedema—Timolol—coronary artery disease	4.53e-05	0.000397	CcSEcCtD
Haloperidol—Anaphylactic shock—Timolol—coronary artery disease	4.53e-05	0.000397	CcSEcCtD
Haloperidol—Pruritus—Pravastatin—coronary artery disease	4.53e-05	0.000396	CcSEcCtD
Haloperidol—Nausea—Clopidogrel—coronary artery disease	4.52e-05	0.000396	CcSEcCtD
Haloperidol—Tachycardia—Ramipril—coronary artery disease	4.52e-05	0.000396	CcSEcCtD
Haloperidol—Skin disorder—Ramipril—coronary artery disease	4.5e-05	0.000394	CcSEcCtD
Haloperidol—Vomiting—Simvastatin—coronary artery disease	4.5e-05	0.000394	CcSEcCtD
Haloperidol—Hypersensitivity—Telmisartan—coronary artery disease	4.5e-05	0.000394	CcSEcCtD
Haloperidol—Nausea—Lovastatin—coronary artery disease	4.49e-05	0.000394	CcSEcCtD
Haloperidol—Hyperhidrosis—Ramipril—coronary artery disease	4.48e-05	0.000392	CcSEcCtD
Haloperidol—Rash—Simvastatin—coronary artery disease	4.46e-05	0.000391	CcSEcCtD
Haloperidol—Dermatitis—Simvastatin—coronary artery disease	4.46e-05	0.00039	CcSEcCtD
Haloperidol—Feeling abnormal—Losartan—coronary artery disease	4.45e-05	0.00039	CcSEcCtD
Haloperidol—Urticaria—Furosemide—coronary artery disease	4.45e-05	0.00039	CcSEcCtD
Haloperidol—Diarrhoea—Niacin—coronary artery disease	4.45e-05	0.000389	CcSEcCtD
Haloperidol—Nervous system disorder—Timolol—coronary artery disease	4.44e-05	0.000389	CcSEcCtD
Haloperidol—Headache—Simvastatin—coronary artery disease	4.43e-05	0.000388	CcSEcCtD
Haloperidol—Body temperature increased—Furosemide—coronary artery disease	4.43e-05	0.000388	CcSEcCtD
Haloperidol—Dizziness—Valsartan—coronary artery disease	4.42e-05	0.000387	CcSEcCtD
Haloperidol—Anorexia—Ramipril—coronary artery disease	4.42e-05	0.000387	CcSEcCtD
Haloperidol—Nausea—Ezetimibe—coronary artery disease	4.41e-05	0.000386	CcSEcCtD
Haloperidol—Skin disorder—Timolol—coronary artery disease	4.4e-05	0.000385	CcSEcCtD
Haloperidol—Dizziness—Olmesartan—coronary artery disease	4.4e-05	0.000385	CcSEcCtD
Haloperidol—Pruritus—Trandolapril—coronary artery disease	4.4e-05	0.000385	CcSEcCtD
Haloperidol—Hyperhidrosis—Timolol—coronary artery disease	4.38e-05	0.000384	CcSEcCtD
Haloperidol—Pruritus—Enalapril—coronary artery disease	4.38e-05	0.000383	CcSEcCtD
Haloperidol—Diarrhoea—Pravastatin—coronary artery disease	4.38e-05	0.000383	CcSEcCtD
Haloperidol—Anxiety—Lisinopril—coronary artery disease	4.37e-05	0.000383	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	4.35e-05	0.000381	CcSEcCtD
Haloperidol—Hypotension—Ramipril—coronary artery disease	4.33e-05	0.000379	CcSEcCtD
Haloperidol—Anorexia—Timolol—coronary artery disease	4.32e-05	0.000378	CcSEcCtD
Haloperidol—Pruritus—Telmisartan—coronary artery disease	4.32e-05	0.000378	CcSEcCtD
Haloperidol—Nausea—Eplerenone—coronary artery disease	4.31e-05	0.000378	CcSEcCtD
Haloperidol—Dizziness—Niacin—coronary artery disease	4.3e-05	0.000376	CcSEcCtD
Haloperidol—Urticaria—Losartan—coronary artery disease	4.29e-05	0.000376	CcSEcCtD
Haloperidol—Dry mouth—Lisinopril—coronary artery disease	4.29e-05	0.000376	CcSEcCtD
Haloperidol—Body temperature increased—Losartan—coronary artery disease	4.27e-05	0.000374	CcSEcCtD
Haloperidol—Diarrhoea—Trandolapril—coronary artery disease	4.25e-05	0.000372	CcSEcCtD
Haloperidol—Vomiting—Valsartan—coronary artery disease	4.25e-05	0.000372	CcSEcCtD
Haloperidol—Confusional state—Lisinopril—coronary artery disease	4.24e-05	0.000371	CcSEcCtD
Haloperidol—Diarrhoea—Enalapril—coronary artery disease	4.23e-05	0.000371	CcSEcCtD
Haloperidol—Hypotension—Timolol—coronary artery disease	4.23e-05	0.000371	CcSEcCtD
Haloperidol—Dizziness—Pravastatin—coronary artery disease	4.23e-05	0.000371	CcSEcCtD
Haloperidol—Vomiting—Olmesartan—coronary artery disease	4.23e-05	0.00037	CcSEcCtD
Haloperidol—Rash—Valsartan—coronary artery disease	4.21e-05	0.000369	CcSEcCtD
Haloperidol—Dermatitis—Valsartan—coronary artery disease	4.21e-05	0.000369	CcSEcCtD
Haloperidol—Nausea—Simvastatin—coronary artery disease	4.2e-05	0.000368	CcSEcCtD
Haloperidol—Oedema—Lisinopril—coronary artery disease	4.2e-05	0.000368	CcSEcCtD
Haloperidol—Anaphylactic shock—Lisinopril—coronary artery disease	4.2e-05	0.000368	CcSEcCtD
Haloperidol—Pruritus—Captopril—coronary artery disease	4.2e-05	0.000368	CcSEcCtD
Haloperidol—Rash—Olmesartan—coronary artery disease	4.19e-05	0.000367	CcSEcCtD
Haloperidol—Insomnia—Ramipril—coronary artery disease	4.19e-05	0.000367	CcSEcCtD
Haloperidol—Dermatitis—Olmesartan—coronary artery disease	4.19e-05	0.000367	CcSEcCtD
Haloperidol—Headache—Valsartan—coronary artery disease	4.19e-05	0.000367	CcSEcCtD
Haloperidol—Diarrhoea—Telmisartan—coronary artery disease	4.18e-05	0.000366	CcSEcCtD
Haloperidol—Headache—Olmesartan—coronary artery disease	4.17e-05	0.000365	CcSEcCtD
Haloperidol—Dyspnoea—Ramipril—coronary artery disease	4.13e-05	0.000362	CcSEcCtD
Haloperidol—Vomiting—Niacin—coronary artery disease	4.13e-05	0.000362	CcSEcCtD
Haloperidol—Hypersensitivity—Furosemide—coronary artery disease	4.13e-05	0.000361	CcSEcCtD
Haloperidol—Somnolence—Ramipril—coronary artery disease	4.12e-05	0.000361	CcSEcCtD
Haloperidol—Thrombocytopenia—Lisinopril—coronary artery disease	4.12e-05	0.00036	CcSEcCtD
Haloperidol—Dizziness—Trandolapril—coronary artery disease	4.11e-05	0.00036	CcSEcCtD
Haloperidol—Tachycardia—Lisinopril—coronary artery disease	4.1e-05	0.000359	CcSEcCtD
Haloperidol—Insomnia—Timolol—coronary artery disease	4.1e-05	0.000359	CcSEcCtD
Haloperidol—Rash—Niacin—coronary artery disease	4.1e-05	0.000359	CcSEcCtD
Haloperidol—Dermatitis—Niacin—coronary artery disease	4.09e-05	0.000359	CcSEcCtD
Haloperidol—Dizziness—Enalapril—coronary artery disease	4.09e-05	0.000358	CcSEcCtD
Haloperidol—Skin disorder—Lisinopril—coronary artery disease	4.08e-05	0.000358	CcSEcCtD
Haloperidol—Dyspepsia—Ramipril—coronary artery disease	4.08e-05	0.000357	CcSEcCtD
Haloperidol—Pruritus—Perindopril—coronary artery disease	4.08e-05	0.000357	CcSEcCtD
Haloperidol—Headache—Niacin—coronary artery disease	4.07e-05	0.000357	CcSEcCtD
Haloperidol—Vomiting—Pravastatin—coronary artery disease	4.07e-05	0.000356	CcSEcCtD
Haloperidol—Hyperhidrosis—Lisinopril—coronary artery disease	4.06e-05	0.000356	CcSEcCtD
Haloperidol—Diarrhoea—Captopril—coronary artery disease	4.06e-05	0.000356	CcSEcCtD
Haloperidol—Dyspnoea—Timolol—coronary artery disease	4.04e-05	0.000354	CcSEcCtD
Haloperidol—Dizziness—Telmisartan—coronary artery disease	4.04e-05	0.000353	CcSEcCtD
Haloperidol—Rash—Pravastatin—coronary artery disease	4.03e-05	0.000353	CcSEcCtD
Haloperidol—Dermatitis—Pravastatin—coronary artery disease	4.03e-05	0.000353	CcSEcCtD
Haloperidol—Decreased appetite—Ramipril—coronary artery disease	4.03e-05	0.000353	CcSEcCtD
Haloperidol—Somnolence—Timolol—coronary artery disease	4.03e-05	0.000353	CcSEcCtD
Haloperidol—Headache—Pravastatin—coronary artery disease	4.01e-05	0.000351	CcSEcCtD
Haloperidol—Anorexia—Lisinopril—coronary artery disease	4.01e-05	0.000351	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Ramipril—coronary artery disease	4e-05	0.00035	CcSEcCtD
Haloperidol—Dyspepsia—Timolol—coronary artery disease	3.99e-05	0.000349	CcSEcCtD
Haloperidol—Hypersensitivity—Losartan—coronary artery disease	3.98e-05	0.000349	CcSEcCtD
Haloperidol—Nausea—Valsartan—coronary artery disease	3.97e-05	0.000348	CcSEcCtD
Haloperidol—Pruritus—Furosemide—coronary artery disease	3.96e-05	0.000347	CcSEcCtD
Haloperidol—Constipation—Ramipril—coronary artery disease	3.96e-05	0.000347	CcSEcCtD
Haloperidol—Nausea—Olmesartan—coronary artery disease	3.95e-05	0.000346	CcSEcCtD
Haloperidol—Vomiting—Trandolapril—coronary artery disease	3.95e-05	0.000346	CcSEcCtD
Haloperidol—Diarrhoea—Perindopril—coronary artery disease	3.94e-05	0.000345	CcSEcCtD
Haloperidol—Decreased appetite—Timolol—coronary artery disease	3.94e-05	0.000345	CcSEcCtD
Haloperidol—Vomiting—Enalapril—coronary artery disease	3.93e-05	0.000345	CcSEcCtD
Haloperidol—Hypotension—Lisinopril—coronary artery disease	3.93e-05	0.000344	CcSEcCtD
Haloperidol—Dizziness—Captopril—coronary artery disease	3.92e-05	0.000344	CcSEcCtD
Haloperidol—Rash—Trandolapril—coronary artery disease	3.92e-05	0.000343	CcSEcCtD
Haloperidol—Dermatitis—Trandolapril—coronary artery disease	3.91e-05	0.000343	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Timolol—coronary artery disease	3.91e-05	0.000343	CcSEcCtD
Haloperidol—Rash—Enalapril—coronary artery disease	3.9e-05	0.000342	CcSEcCtD
Haloperidol—Dermatitis—Enalapril—coronary artery disease	3.9e-05	0.000341	CcSEcCtD
Haloperidol—Headache—Trandolapril—coronary artery disease	3.89e-05	0.000341	CcSEcCtD
Haloperidol—Vomiting—Telmisartan—coronary artery disease	3.88e-05	0.00034	CcSEcCtD
Haloperidol—Headache—Enalapril—coronary artery disease	3.88e-05	0.00034	CcSEcCtD
Haloperidol—Nausea—Niacin—coronary artery disease	3.86e-05	0.000338	CcSEcCtD
Haloperidol—Rash—Telmisartan—coronary artery disease	3.85e-05	0.000337	CcSEcCtD
Haloperidol—Dermatitis—Telmisartan—coronary artery disease	3.85e-05	0.000337	CcSEcCtD
Haloperidol—Diarrhoea—Furosemide—coronary artery disease	3.83e-05	0.000336	CcSEcCtD
Haloperidol—Pruritus—Losartan—coronary artery disease	3.82e-05	0.000335	CcSEcCtD
Haloperidol—Headache—Telmisartan—coronary artery disease	3.82e-05	0.000335	CcSEcCtD
Haloperidol—Feeling abnormal—Ramipril—coronary artery disease	3.82e-05	0.000334	CcSEcCtD
Haloperidol—Dizziness—Perindopril—coronary artery disease	3.81e-05	0.000334	CcSEcCtD
Haloperidol—Insomnia—Lisinopril—coronary artery disease	3.8e-05	0.000333	CcSEcCtD
Haloperidol—Nausea—Pravastatin—coronary artery disease	3.8e-05	0.000333	CcSEcCtD
Haloperidol—Vomiting—Captopril—coronary artery disease	3.77e-05	0.000331	CcSEcCtD
Haloperidol—Dyspnoea—Lisinopril—coronary artery disease	3.75e-05	0.000328	CcSEcCtD
Haloperidol—Rash—Captopril—coronary artery disease	3.74e-05	0.000328	CcSEcCtD
Haloperidol—Dermatitis—Captopril—coronary artery disease	3.74e-05	0.000327	CcSEcCtD
Haloperidol—Somnolence—Lisinopril—coronary artery disease	3.74e-05	0.000327	CcSEcCtD
Haloperidol—Feeling abnormal—Timolol—coronary artery disease	3.73e-05	0.000327	CcSEcCtD
Haloperidol—Headache—Captopril—coronary artery disease	3.72e-05	0.000326	CcSEcCtD
Haloperidol—Dizziness—Furosemide—coronary artery disease	3.7e-05	0.000324	CcSEcCtD
Haloperidol—Dyspepsia—Lisinopril—coronary artery disease	3.7e-05	0.000324	CcSEcCtD
Haloperidol—Diarrhoea—Losartan—coronary artery disease	3.7e-05	0.000324	CcSEcCtD
Haloperidol—Nausea—Trandolapril—coronary artery disease	3.69e-05	0.000323	CcSEcCtD
Haloperidol—Urticaria—Ramipril—coronary artery disease	3.68e-05	0.000322	CcSEcCtD
Haloperidol—Nausea—Enalapril—coronary artery disease	3.68e-05	0.000322	CcSEcCtD
Haloperidol—Vomiting—Perindopril—coronary artery disease	3.66e-05	0.000321	CcSEcCtD
Haloperidol—Body temperature increased—Ramipril—coronary artery disease	3.66e-05	0.000321	CcSEcCtD
Haloperidol—Decreased appetite—Lisinopril—coronary artery disease	3.65e-05	0.00032	CcSEcCtD
Haloperidol—Rash—Perindopril—coronary artery disease	3.63e-05	0.000318	CcSEcCtD
Haloperidol—Dermatitis—Perindopril—coronary artery disease	3.63e-05	0.000318	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.63e-05	0.000318	CcSEcCtD
Haloperidol—Nausea—Telmisartan—coronary artery disease	3.63e-05	0.000318	CcSEcCtD
Haloperidol—Headache—Perindopril—coronary artery disease	3.61e-05	0.000316	CcSEcCtD
Haloperidol—Urticaria—Timolol—coronary artery disease	3.6e-05	0.000315	CcSEcCtD
Haloperidol—Constipation—Lisinopril—coronary artery disease	3.59e-05	0.000315	CcSEcCtD
Haloperidol—Body temperature increased—Timolol—coronary artery disease	3.58e-05	0.000314	CcSEcCtD
Haloperidol—Dizziness—Losartan—coronary artery disease	3.57e-05	0.000313	CcSEcCtD
Haloperidol—Vomiting—Furosemide—coronary artery disease	3.56e-05	0.000312	CcSEcCtD
Haloperidol—Rash—Furosemide—coronary artery disease	3.53e-05	0.000309	CcSEcCtD
Haloperidol—Dermatitis—Furosemide—coronary artery disease	3.53e-05	0.000309	CcSEcCtD
Haloperidol—Nausea—Captopril—coronary artery disease	3.53e-05	0.000309	CcSEcCtD
Haloperidol—Headache—Furosemide—coronary artery disease	3.51e-05	0.000307	CcSEcCtD
Haloperidol—Feeling abnormal—Lisinopril—coronary artery disease	3.46e-05	0.000303	CcSEcCtD
Haloperidol—Vomiting—Losartan—coronary artery disease	3.44e-05	0.000301	CcSEcCtD
Haloperidol—Nausea—Perindopril—coronary artery disease	3.42e-05	0.0003	CcSEcCtD
Haloperidol—Hypersensitivity—Ramipril—coronary artery disease	3.41e-05	0.000299	CcSEcCtD
Haloperidol—Rash—Losartan—coronary artery disease	3.41e-05	0.000298	CcSEcCtD
Haloperidol—Dermatitis—Losartan—coronary artery disease	3.4e-05	0.000298	CcSEcCtD
Haloperidol—Headache—Losartan—coronary artery disease	3.39e-05	0.000297	CcSEcCtD
Haloperidol—Urticaria—Lisinopril—coronary artery disease	3.34e-05	0.000292	CcSEcCtD
Haloperidol—Hypersensitivity—Timolol—coronary artery disease	3.34e-05	0.000292	CcSEcCtD
Haloperidol—Nausea—Furosemide—coronary artery disease	3.33e-05	0.000291	CcSEcCtD
Haloperidol—Body temperature increased—Lisinopril—coronary artery disease	3.32e-05	0.000291	CcSEcCtD
Haloperidol—Pruritus—Ramipril—coronary artery disease	3.28e-05	0.000287	CcSEcCtD
Haloperidol—Nausea—Losartan—coronary artery disease	3.21e-05	0.000281	CcSEcCtD
Haloperidol—Pruritus—Timolol—coronary artery disease	3.21e-05	0.000281	CcSEcCtD
Haloperidol—Diarrhoea—Ramipril—coronary artery disease	3.17e-05	0.000278	CcSEcCtD
Haloperidol—Diarrhoea—Timolol—coronary artery disease	3.1e-05	0.000272	CcSEcCtD
Haloperidol—Hypersensitivity—Lisinopril—coronary artery disease	3.1e-05	0.000271	CcSEcCtD
Haloperidol—Dizziness—Ramipril—coronary artery disease	3.06e-05	0.000268	CcSEcCtD
Haloperidol—Dizziness—Timolol—coronary artery disease	3e-05	0.000262	CcSEcCtD
Haloperidol—Pruritus—Lisinopril—coronary artery disease	2.97e-05	0.00026	CcSEcCtD
Haloperidol—Vomiting—Ramipril—coronary artery disease	2.95e-05	0.000258	CcSEcCtD
Haloperidol—Rash—Ramipril—coronary artery disease	2.92e-05	0.000256	CcSEcCtD
Haloperidol—Dermatitis—Ramipril—coronary artery disease	2.92e-05	0.000256	CcSEcCtD
Haloperidol—Headache—Ramipril—coronary artery disease	2.9e-05	0.000254	CcSEcCtD
Haloperidol—Vomiting—Timolol—coronary artery disease	2.88e-05	0.000252	CcSEcCtD
Haloperidol—Diarrhoea—Lisinopril—coronary artery disease	2.88e-05	0.000252	CcSEcCtD
Haloperidol—Rash—Timolol—coronary artery disease	2.86e-05	0.00025	CcSEcCtD
Haloperidol—Dermatitis—Timolol—coronary artery disease	2.85e-05	0.00025	CcSEcCtD
Haloperidol—Headache—Timolol—coronary artery disease	2.84e-05	0.000249	CcSEcCtD
Haloperidol—Dizziness—Lisinopril—coronary artery disease	2.78e-05	0.000243	CcSEcCtD
Haloperidol—Nausea—Ramipril—coronary artery disease	2.75e-05	0.000241	CcSEcCtD
Haloperidol—Nausea—Timolol—coronary artery disease	2.69e-05	0.000236	CcSEcCtD
Haloperidol—Vomiting—Lisinopril—coronary artery disease	2.67e-05	0.000234	CcSEcCtD
Haloperidol—Rash—Lisinopril—coronary artery disease	2.65e-05	0.000232	CcSEcCtD
Haloperidol—Dermatitis—Lisinopril—coronary artery disease	2.65e-05	0.000232	CcSEcCtD
Haloperidol—Headache—Lisinopril—coronary artery disease	2.63e-05	0.000231	CcSEcCtD
Haloperidol—Nausea—Lisinopril—coronary artery disease	2.5e-05	0.000219	CcSEcCtD
Haloperidol—CYP2C19—Metabolism—PPP2CA—coronary artery disease	9.89e-07	1.17e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GSTM1—coronary artery disease	9.87e-07	1.17e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—POMC—coronary artery disease	9.84e-07	1.16e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CREB1—coronary artery disease	9.84e-07	1.16e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MMP9—coronary artery disease	9.83e-07	1.16e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—POMC—coronary artery disease	9.82e-07	1.16e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CREB1—coronary artery disease	9.82e-07	1.16e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—POMC—coronary artery disease	9.81e-07	1.16e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CASP3—coronary artery disease	9.81e-07	1.16e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GSTM1—coronary artery disease	9.79e-07	1.16e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCL2—coronary artery disease	9.79e-07	1.16e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CD36—coronary artery disease	9.77e-07	1.16e-05	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—AKT1—coronary artery disease	9.77e-07	1.16e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6R—coronary artery disease	9.76e-07	1.15e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL6—coronary artery disease	9.75e-07	1.15e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—LPL—coronary artery disease	9.69e-07	1.15e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CASP3—coronary artery disease	9.68e-07	1.15e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPP2CA—coronary artery disease	9.65e-07	1.14e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCL2—coronary artery disease	9.63e-07	1.14e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IGF1—coronary artery disease	9.62e-07	1.14e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL6—coronary artery disease	9.62e-07	1.14e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCL2—coronary artery disease	9.61e-07	1.14e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—LPL—coronary artery disease	9.61e-07	1.14e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6R—coronary artery disease	9.6e-07	1.14e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VEGFA—coronary artery disease	9.6e-07	1.14e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6R—coronary artery disease	9.58e-07	1.13e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	9.58e-07	1.13e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCND1—coronary artery disease	9.55e-07	1.13e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—AKT1—coronary artery disease	9.53e-07	1.13e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—MTHFR—coronary artery disease	9.49e-07	1.12e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IGF1—coronary artery disease	9.47e-07	1.12e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GPX1—coronary artery disease	9.46e-07	1.12e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IGF1—coronary artery disease	9.45e-07	1.12e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	9.42e-07	1.11e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCND1—coronary artery disease	9.42e-07	1.11e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	9.4e-07	1.11e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PPARG—coronary artery disease	9.4e-07	1.11e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	9.4e-07	1.11e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GPX1—coronary artery disease	9.37e-07	1.11e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PSMA6—coronary artery disease	9.36e-07	1.11e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PSMB5—coronary artery disease	9.36e-07	1.11e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—POMC—coronary artery disease	9.27e-07	1.1e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MMP9—coronary artery disease	9.27e-07	1.1e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—MTHFR—coronary artery disease	9.26e-07	1.1e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VEGFA—coronary artery disease	9.25e-07	1.09e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CD36—coronary artery disease	9.21e-07	1.09e-05	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	9.15e-07	1.08e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MMP9—coronary artery disease	9.15e-07	1.08e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CTGF—coronary artery disease	9.14e-07	1.08e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	9.14e-07	1.08e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CD36—coronary artery disease	9.13e-07	1.08e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GSTP1—coronary artery disease	9.1e-07	1.08e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPP2CA—coronary artery disease	9.09e-07	1.08e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—HMGCR—coronary artery disease	9.06e-07	1.07e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GOT2—coronary artery disease	9.06e-07	1.07e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	9.02e-07	1.07e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPP2CA—coronary artery disease	9.01e-07	1.07e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AGT—coronary artery disease	9.01e-07	1.07e-05	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	9e-07	1.07e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AKT1—coronary artery disease	8.99e-07	1.06e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	8.99e-07	1.06e-05	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	8.98e-07	1.06e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—HMOX1—coronary artery disease	8.98e-07	1.06e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	8.97e-07	1.06e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ALB—coronary artery disease	8.95e-07	1.06e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AKT1—coronary artery disease	8.87e-07	1.05e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CAT—coronary artery disease	8.86e-07	1.05e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FGF2—coronary artery disease	8.85e-07	1.05e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOE—coronary artery disease	8.83e-07	1.04e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	8.83e-07	1.04e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	8.81e-07	1.04e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AGT—coronary artery disease	8.8e-07	1.04e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOA1—coronary artery disease	8.73e-07	1.03e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MTHFR—coronary artery disease	8.73e-07	1.03e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOS3—coronary artery disease	8.72e-07	1.03e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FGF2—coronary artery disease	8.7e-07	1.03e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FGF2—coronary artery disease	8.69e-07	1.03e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MTHFR—coronary artery disease	8.65e-07	1.02e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	8.64e-07	1.02e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	8.63e-07	1.02e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOE—coronary artery disease	8.62e-07	1.02e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOB—coronary artery disease	8.6e-07	1.02e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOS3—coronary artery disease	8.58e-07	1.02e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOS3—coronary artery disease	8.57e-07	1.01e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—NOS3—coronary artery disease	8.56e-07	1.01e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOA1—coronary artery disease	8.52e-07	1.01e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TGFB1—coronary artery disease	8.49e-07	1e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—JAK2—coronary artery disease	8.48e-07	1e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	8.46e-07	1e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ALB—coronary artery disease	8.45e-07	1e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GSTM1—coronary artery disease	8.36e-07	9.9e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.36e-07	9.89e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—JAK2—coronary artery disease	8.34e-07	9.87e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PLCB1—coronary artery disease	8.33e-07	9.86e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—JAK2—coronary artery disease	8.32e-07	9.85e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—coronary artery disease	8.32e-07	9.85e-06	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MAPK1—coronary artery disease	8.32e-07	9.85e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	8.31e-07	9.83e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AGT—coronary artery disease	8.29e-07	9.81e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AGT—coronary artery disease	8.22e-07	9.72e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—coronary artery disease	8.21e-07	9.72e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—LPL—coronary artery disease	8.21e-07	9.71e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	8.18e-07	9.67e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	8.16e-07	9.65e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOE—coronary artery disease	8.12e-07	9.61e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	8.1e-07	9.58e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—NOS3—coronary artery disease	8.09e-07	9.57e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ABCA1—coronary artery disease	8.07e-07	9.55e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOE—coronary artery disease	8.05e-07	9.53e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOA1—coronary artery disease	8.03e-07	9.5e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GPX1—coronary artery disease	8.01e-07	9.48e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOA1—coronary artery disease	7.96e-07	9.42e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	7.95e-07	9.4e-06	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PIK3CA—coronary artery disease	7.92e-07	9.37e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—coronary artery disease	7.83e-07	9.26e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GOT1—coronary artery disease	7.82e-07	9.25e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GGT1—coronary artery disease	7.82e-07	9.25e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CD36—coronary artery disease	7.8e-07	9.23e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CXCL8—coronary artery disease	7.74e-07	9.15e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPP2CA—coronary artery disease	7.7e-07	9.11e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARG—coronary artery disease	7.69e-07	9.1e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TGFB1—coronary artery disease	7.64e-07	9.04e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.62e-07	9.02e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	7.61e-07	9.01e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CXCL8—coronary artery disease	7.6e-07	8.99e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—POMC—coronary artery disease	7.59e-07	8.98e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TGFB1—coronary artery disease	7.54e-07	8.92e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARG—coronary artery disease	7.51e-07	8.88e-06	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	7.5e-07	8.87e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MAPK1—coronary artery disease	7.49e-07	8.86e-06	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	7.48e-07	8.84e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CASP3—coronary artery disease	7.41e-07	8.76e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—POMC—coronary artery disease	7.41e-07	8.76e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—coronary artery disease	7.4e-07	8.75e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MAPK1—coronary artery disease	7.39e-07	8.75e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MTHFR—coronary artery disease	7.39e-07	8.75e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6—coronary artery disease	7.36e-07	8.71e-06	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	7.36e-07	8.7e-06	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	7.34e-07	8.68e-06	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	7.34e-07	8.68e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CASP3—coronary artery disease	7.29e-07	8.62e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CASP3—coronary artery disease	7.27e-07	8.6e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6—coronary artery disease	7.24e-07	8.57e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6—coronary artery disease	7.22e-07	8.55e-06	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	7.22e-07	8.54e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCND1—coronary artery disease	7.21e-07	8.53e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCND1—coronary artery disease	7.09e-07	8.39e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCND1—coronary artery disease	7.08e-07	8.37e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARG—coronary artery disease	7.08e-07	8.37e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GSTP1—coronary artery disease	7.02e-07	8.31e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AGT—coronary artery disease	7.02e-07	8.31e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARG—coronary artery disease	7.01e-07	8.3e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MMP9—coronary artery disease	7e-07	8.28e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—POMC—coronary artery disease	6.98e-07	8.26e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	6.96e-07	8.23e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—HMOX1—coronary artery disease	6.93e-07	8.2e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—POMC—coronary artery disease	6.92e-07	8.18e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ALB—coronary artery disease	6.92e-07	8.18e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	6.89e-07	8.16e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MMP9—coronary artery disease	6.89e-07	8.15e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOE—coronary artery disease	6.88e-07	8.14e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MMP9—coronary artery disease	6.87e-07	8.13e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CAT—coronary artery disease	6.84e-07	8.09e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOA1—coronary artery disease	6.8e-07	8.05e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AKT1—coronary artery disease	6.79e-07	8.03e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ALB—coronary artery disease	6.75e-07	7.99e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	6.68e-07	7.9e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AKT1—coronary artery disease	6.67e-07	7.89e-06	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PIK3CA—coronary artery disease	6.66e-07	7.88e-06	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6—coronary artery disease	6.64e-07	7.85e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOB—coronary artery disease	6.64e-07	7.85e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—NOS3—coronary artery disease	6.62e-07	7.83e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.51e-07	7.71e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	6.5e-07	7.69e-06	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6—coronary artery disease	6.5e-07	7.69e-06	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—AKT1—coronary artery disease	6.47e-07	7.66e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—NOS3—coronary artery disease	6.46e-07	7.64e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GSTM1—coronary artery disease	6.46e-07	7.64e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	6.42e-07	7.59e-06	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6—coronary artery disease	6.4e-07	7.57e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ALB—coronary artery disease	6.36e-07	7.53e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—LPL—coronary artery disease	6.34e-07	7.5e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ALB—coronary artery disease	6.31e-07	7.46e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—coronary artery disease	6.29e-07	7.44e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	6.18e-07	7.32e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GPX1—coronary artery disease	6.18e-07	7.31e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—coronary artery disease	6.17e-07	7.3e-06	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AKT1—coronary artery disease	6.12e-07	7.24e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6—coronary artery disease	6.11e-07	7.22e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—NOS3—coronary artery disease	6.09e-07	7.2e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—coronary artery disease	6.05e-07	7.16e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—NOS3—coronary artery disease	6.03e-07	7.14e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CD36—coronary artery disease	6.02e-07	7.12e-06	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AKT1—coronary artery disease	6e-07	7.09e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARG—coronary artery disease	5.99e-07	7.09e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.95e-07	7.03e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—POMC—coronary artery disease	5.91e-07	6.99e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—coronary artery disease	5.91e-07	6.99e-06	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AKT1—coronary artery disease	5.9e-07	6.98e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TGFB1—coronary artery disease	5.77e-07	6.82e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6—coronary artery disease	5.76e-07	6.81e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MTHFR—coronary artery disease	5.71e-07	6.75e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6—coronary artery disease	5.68e-07	6.72e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	5.68e-07	6.72e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TGFB1—coronary artery disease	5.66e-07	6.7e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MAPK1—coronary artery disease	5.66e-07	6.69e-06	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AKT1—coronary artery disease	5.63e-07	6.66e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	5.57e-07	6.59e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—coronary artery disease	5.57e-07	6.59e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MAPK1—coronary artery disease	5.55e-07	6.57e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—coronary artery disease	5.52e-07	6.53e-06	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—AKT1—coronary artery disease	5.44e-07	6.44e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AGT—coronary artery disease	5.42e-07	6.41e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ALB—coronary artery disease	5.39e-07	6.38e-06	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AKT1—coronary artery disease	5.31e-07	6.28e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOE—coronary artery disease	5.31e-07	6.28e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOA1—coronary artery disease	5.25e-07	6.21e-06	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AKT1—coronary artery disease	5.24e-07	6.2e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NOS3—coronary artery disease	5.16e-07	6.1e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	4.91e-07	5.81e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	4.83e-07	5.71e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	4.82e-07	5.7e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3CA—coronary artery disease	4.82e-07	5.7e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—coronary artery disease	4.72e-07	5.58e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARG—coronary artery disease	4.63e-07	5.47e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—POMC—coronary artery disease	4.56e-07	5.4e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3CA—coronary artery disease	4.55e-07	5.38e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6—coronary artery disease	4.35e-07	5.14e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6—coronary artery disease	4.28e-07	5.06e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6—coronary artery disease	4.27e-07	5.05e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ALB—coronary artery disease	4.16e-07	4.92e-06	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AKT1—coronary artery disease	4.01e-07	4.74e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NOS3—coronary artery disease	3.98e-07	4.71e-06	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AKT1—coronary artery disease	3.95e-07	4.67e-06	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AKT1—coronary artery disease	3.94e-07	4.66e-06	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—AKT1—coronary artery disease	3.93e-07	4.65e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CA—coronary artery disease	3.72e-07	4.4e-06	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—AKT1—coronary artery disease	3.72e-07	4.4e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.64e-07	4.31e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CA—coronary artery disease	3.63e-07	4.3e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CA—coronary artery disease	3.42e-07	4.05e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CA—coronary artery disease	3.39e-07	4.02e-06	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AKT1—coronary artery disease	3.04e-07	3.6e-06	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AKT1—coronary artery disease	2.97e-07	3.51e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.9e-07	3.43e-06	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AKT1—coronary artery disease	2.8e-07	3.31e-06	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AKT1—coronary artery disease	2.77e-07	3.28e-06	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AKT1—coronary artery disease	2.37e-07	2.8e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.24e-07	2.65e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AKT1—coronary artery disease	1.83e-07	2.16e-06	CbGpPWpGaD
